+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ovarian"

From
From
From
From
From
From
Ovarian Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Ovarian Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 450 Pages
  • Global
From
Advanced ovarian cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced ovarian cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 210 Pages
  • Global
From
Epithelial Ovarian Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Epithelial Ovarian Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Polycystic ovarian syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Polycystic ovarian syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Advanced Recurrent Ovarian Cancer Market - Product Thumbnail Image

Advanced Recurrent Ovarian Cancer Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Advanced Ovarian Cancer Market - Product Thumbnail Image

Advanced Ovarian Cancer Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Ovarian Cancer Pipeline Analysis Report - Product Thumbnail Image

Ovarian Cancer Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
From
From
Loading Indicator

The Ovarian market is a segment of the Women's Health industry that focuses on the diagnosis, treatment, and prevention of ovarian diseases. It includes products and services related to the diagnosis, treatment, and prevention of ovarian cancer, ovarian cysts, and other ovarian disorders. The market also includes products and services related to fertility, contraception, and hormone replacement therapy. The Ovarian market is driven by the increasing prevalence of ovarian diseases, the growing awareness of the importance of early diagnosis and treatment, and the increasing demand for fertility treatments. Additionally, the development of new technologies and treatments for ovarian diseases is expected to drive the market growth. Some companies in the Ovarian market include AbbVie, AstraZeneca, Bayer, Merck, Novartis, Pfizer, and Roche. Show Less Read more